MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 263 filers reported holding MYRIAD GENETICS INC in Q1 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $5,000 | 0.0% | 200 | +25.0% | 0.00% | -33.3% |
| Q3 2019 | $5,000 | +25.0% | 160 | 0.0% | 0.00% | +50.0% |
| Q2 2019 | $4,000 | -20.0% | 160 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $5,000 | 0.0% | 160 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $5,000 | -44.4% | 160 | -20.0% | 0.00% | -40.0% |
| Q3 2018 | $9,000 | +28.6% | 200 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $7,000 | +16.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $6,000 | -14.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $7,000 | -99.9% | 200 | -33.3% | 0.00% | -42.9% |
| Q3 2017 | $10,854,000 | +40.0% | 300 | 0.0% | 0.01% | +40.0% |
| Q2 2017 | $7,752,000 | +39.7% | 300 | 0.0% | 0.01% | +25.0% |
| Q1 2017 | $5,550,000 | +110900.0% | 300 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $5,000 | -50.0% | 300 | 0.0% | 0.00% | -57.1% |
| Q2 2016 | $10,000 | +100.0% | 300 | +114.3% | 0.01% | +133.3% |
| Q1 2016 | $5,000 | – | 140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,646,330 | $75,731,000 | 4.08% |
| Tieton Capital Management, LLC | 91,948 | $4,230,000 | 3.37% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 369,355 | $16,990,000 | 1.54% |
| S&T BANK/PA | 165,071 | $7,594,000 | 1.42% |
| Millrace Asset Group, Inc. | 38,972 | $1,793,000 | 1.40% |
| Taylor Frigon Capital Management LLC | 39,929 | $1,836,000 | 1.39% |
| Summit Street Capital Management, LLC | 30,097 | $1,384,000 | 1.35% |
| AIMZ Investment Advisors, LLC | 43,485 | $2,000,000 | 1.29% |
| Matarin Capital Management, LLC | 413,193 | $19,006,878,000 | 1.22% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,357,351 | $62,438,000 | 1.05% |